Fensolvi is an injectable medication that must be administered by a healthcare professional. Here’s a step-by-step outline of the process:

• Consultation with Healthcare Provider: Before starting treatment with Fensolvi, the child will need a thorough evaluation by their doctor, which may include laboratory tests to confirm the diagnosis of central precocious puberty (CPP).
  
  
• Injection Procedure: Fensolvi is prepared by mixing the powdered medication with a diluent (provided with the medication). The healthcare professional will inject the mixed solution into a large muscle, typically in the buttock or thigh. The injection is usually painless, but the child may feel a brief sting at the injection site.
  
  
• Follow-up Visits: After receiving the injection, the child will typically need a follow-up visit to monitor the response to the medication and check for any potential side effects. Fensolvi is typically administered every 6 months, so follow-up visits will also be scheduled to ensure the child is responding to the treatment as expected.
  
  

Discontinuation of Treatment: When Fensolvi treatment is stopped, puberty will typically resume within a few months, and the child will continue developing at the normal pace for their age.

Fensolvi works through its active ingredient, leuprolide acetate, which is a synthetic form of a naturally occurring hormone called gonadotropin-releasing hormone (GnRH). Here’s how Fensolvi works in the body:

• GnRH Agonist Action: Normally, GnRH is produced in the brain and signals the release of gonadotropins, which are hormones that control the production of sex hormones (estrogen in females, testosterone in males). These hormones are responsible for the physical changes of puberty, such as breast development in girls or testicular enlargement in boys.
  
  
• Suppression of Gonadotropins: When Fensolvi is administered, the synthetic GnRH (leuprolide acetate) initially stimulates the pituitary gland to release gonadotropins. However, with continued use, the body becomes desensitized to GnRH, causing a reduction in the release of gonadotropins. As a result, there is a decrease in the production of estrogen and testosterone, which temporarily halts the progression of puberty.
  
  
• Temporary Suspension of Puberty: By reducing the levels of sex hormones, Fensolvi effectively halts early puberty. This gives children more time to grow and develop physically and emotionally at a more typical pace. In some cases, the treatment allows them to reach their full growth potential by delaying the closure of their growth plates.
  
  

The effect of Fensolvi is reversible. After discontinuation of the medication, puberty will resume, and the child will continue to develop normally. Fensolvi does not cure CPP but manages the symptoms and delays puberty to ensure the child’s growth and emotional development occur at the appropriate time.

As with all medications, Fensolvi can cause side effects. However, not all children will experience them. Most side effects are mild and go away with time, but it is important to be aware of potential adverse effects.

Common Side Effects:

• Injection site reactions: Some children may experience mild discomfort, redness, or swelling at the injection site.
  
  
• Headache: Headaches are a relatively common side effect during treatment with Fensolvi.
  
  
• Mood changes: Children undergoing treatment for CPP may experience mood swings, irritability, or emotional changes as they transition through the hormonal changes of puberty.
  
  
• Hot flashes: Some children may experience hot flashes or a sensation of feeling too warm as their bodies adjust to the medication.
  
  
• Abdominal pain: Mild stomach discomfort or abdominal pain may occur during treatment.
  
  

Serious Side Effects:

• Bone health: Because Fensolvi suppresses sex hormones, there is a slight risk of affecting bone density over time. It’s important for the doctor to monitor bone health throughout treatment.
  
  
• Ovarian cysts (in females): Some females may develop ovarian cysts during treatment with Fensolvi, which are usually harmless but should be monitored by the healthcare provider.
  
  
• Allergic reactions: Although rare, some children may experience severe allergic reactions, including difficulty breathing, swelling of the face or throat, or a rash. Immediate medical attention is required if any signs of an allergic reaction appear.
  
  

If any unusual or severe side effects occur, it’s important to contact a healthcare provider immediately.

• Bone health: As Fensolvi temporarily suppresses sex hormones, there may be an impact on bone density over time. This is usually monitored by doctors during the course of treatment.
  
  
• Pregnancy: Fensolvi should not be used during pregnancy, as it could harm a developing fetus. It is important for female patients to avoid becoming pregnant while on this medication.
  
  
• Children under 2 years: Fensolvi is typically not recommended for children younger than 2 years old, as the safety and effectiveness have not been established for this age group.
  
  

Breastfeeding: The effects of Fensolvi on breast milk are not fully understood, so it is important to discuss the risks and benefits with the doctor if the child is breastfeeding.

• Injections are administered in a clinical or healthcare setting by a trained healthcare provider.
  
  
• Preparation: Fensolvi is a lyophilized powder that must be mixed with a diluent before being injected. This preparation should only be done by a healthcare professional to ensure proper dosage and sterility.
  
  
• Injection Site: The injection is typically given in the gluteal (buttock) muscle or the thigh muscle.
  
  

Before starting Fensolvi, your healthcare provider will discuss the injection schedule and other aspe

Fensolvi is administered as a single injection every 6 months. The dosage is generally based on the age and weight of the child. The standard dose is 45 mg for children aged 2 years and older with central precocious puberty.

Always follow the doctor’s prescribed dosage schedule, as it will be tailored to the child’s specific needs.

Fensolvi is a prescription medication, and its use must be supervised by a healthcare provider. Before starting treatment, a doctor will need to diagnose central precocious puberty and assess whether Fensolvi is the appropriate medication for the child.

• What is Fensolvi used for?
  It is used to treat central precocious puberty (CPP) — a condition in which children enter puberty too early (before age 8 in girls and 9 in boys).
  It helps delay early sexual development by reducing hormone levels that trigger puberty.

• What is the active ingredient?
  Leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist.

• How does Fensolvi work?
  It acts on the pituitary gland to temporarily suppress the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
  This reduces the production of estrogen and testosterone, effectively pausing puberty until the appropriate age.

• What type of medication is it?
  A long-acting GnRH agonist injection (hormone therapy).

• How is Fensolvi administered?
  It is given as a subcutaneous injection (under the skin) by a healthcare professional every 6 months.

• What is the dosage form and strength?
  Fensolvi 45 mg injection (leuprolide acetate for depot suspension).

• How long does Fensolvi last?
  Each injection provides continuous hormone suppression for 6 months.

• What are the common side effects?

  • Injection site pain or redness

  • Headache

  • Hot flashes or sweating

  • Mood swings or irritability

  • Fatigue

  • Nausea

• Are there serious side effects?
  Yes, though rare — contact your doctor if your child experiences:

  • Seizures

  • Severe mood changes or depression

  • Allergic reactions (rash, swelling, trouble breathing)

  • Symptoms of high blood sugar (increased thirst, frequent urination)

• Does Fensolvi cause an initial flare-up?
  Yes — in the first 2–4 weeks, hormone levels may temporarily rise before declining, causing brief pubertal symptoms (like spotting or breast tenderness).

• How long does Fensolvi take to work?
  Full suppression of puberty typically occurs within 1–2 months after the injection.

• Can Fensolvi cause mood or behavior changes?
  Yes — irritability, sadness, or mood swings can occur, though they’re usually mild and temporary.

• Does Fensolvi affect height?
  Yes — by delaying early puberty, it allows for continued bone growth, helping children reach normal adult height potential.

• How long is Fensolvi treatment continued?
  Usually until the normal age of puberty, when treatment is stopped to allow natural puberty to resume.

• Can Fensolvi be used in adults?
  No — it is approved only for children with central precocious puberty.

• Can Fensolvi affect fertility later in life?
  No — puberty and fertility return to normal after treatment is stopped.

• Does Fensolvi require monitoring?
  Yes — doctors monitor:

  • Growth rate and bone age

  • Hormone levels (LH, FSH, estradiol/testosterone)

  • Pubertal signs and behavior changes

• Can Fensolvi be used during pregnancy?
  No — it is contraindicated in pregnancy and should not be used by females who are or may become pregnant.

• Can Fensolvi be used with other medications?
  Usually safe, but always inform the doctor about all medications, including insulin, antidiabetic drugs, antidepressants, and seizure medications.

• What happens if an injection is missed or delayed?
  Contact the doctor as soon as possible to reschedule the missed dose, as delayed injections can cause puberty to restart.

• How should Fensolvi be stored?
  Stored and prepared by healthcare professionals — not typically handled at home.

• Is there a generic version available?
  No — Fensolvi is available as brand only.

• Where is Fensolvi given?
  Administered in a clinic or doctor’s office by trained healthcare providers.